|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate, at cost | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Total real estate, net | ||||||||||||||||||||
| Lease intangibles, net | ||||||||||||||||||||
| Real estate and related assets held for sale | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Funds held in escrow | ||||||||||||||||||||
| Right-of-use assets from operating leases | ||||||||||||||||||||
| Right-of-use assets from finance leases, net | ||||||||||||||||||||
| Deferred rent receivable, net | ||||||||||||||||||||
| Sales-type lease receivable, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Mortgage notes payable, net | ||||||||||||||||||||
| Borrowings under Revolver | ||||||||||||||||||||
| Borrowings under Term Loan A, Term Loan B and Term Loan C, net | ||||||||||||||||||||
| Borrowings under unsecured Term Loan D, net | ||||||||||||||||||||
| Senior unsecured notes, net | ||||||||||||||||||||
| Deferred rent liability, net | ||||||||||||||||||||
| Advance rent | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| MEZZANINE EQUITY | ||||||||||||||||||||
| Series E and G redeemable preferred stock, net, par value $0.001 per share; $25 per share liquidation preference; 10,750,886 and 10,750,886 shares authorized; and 7,052,334 and 7,052,334 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Senior common stock, par value $0.001 per share; 950,000 shares authorized; and 378,766 and 379,223 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock, par value $0.001 per share, 62,639,994 and 62,599,663 shares authorized; and 48,407,375 and 48,406,993 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Series F redeemable preferred stock, par value $0.001 per share; $25 per share liquidation preference; 25,659,120 and 25,699,451 shares authorized and 717,459 and 750,247 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Distributions in excess of accumulated earnings | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| OP Units held by Non-controlling OP Unitholders | ||||||||||||||||||||
| TOTAL EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES, MEZZANINE EQUITY AND EQUITY | ||||||||||||||||||||
Loading...
